Form 4: Encompass Health Director Gains Shares via Dividend
Insider Transaction Report
Encompass Health Director Nancy M. Schlichting received 40 restricted stock units as part of a dividend payment on January 15, 2026, increasing her direct beneficial ownership to 21,259 shares.
Summary
- Nancy M. Schlichting, a Director of Encompass Health Corp (EHC), acquired 40 restricted stock units (RSUs).
- The acquisition occurred on January 15, 2026, and was related to a common stock dividend payment.
- Encompass Health paid a dividend of $0.19 per share on its common stock.
- The closing price of Encompass Health stock on the dividend payment date was $102.80.
- Following this transaction, Ms. Schlichting directly beneficially owns 21,259 shares of Encompass Health Common Stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: The filing reports a routine acquisition of restricted stock units by a director due to a dividend payment, reflecting standard compensation practices and a dividend distribution by the company. This is a neutral to slightly positive event.
Positives
- Director Nancy M. Schlichting's beneficial ownership in Encompass Health Corp increased to 21,259 shares, aligning her interests further with shareholders.
- The company paid a common stock dividend of $0.19 per share, indicating a return to shareholders.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compliance/Policy Adherence | The transaction was executed under a Rule 10b5-1(c) plan, indicating pre-arranged trading to avoid insider trading allegations. | 01/15/2026 | Enhances transparency and compliance with insider trading regulations, demonstrating adherence to best practices for insider transactions. |
Related Party Transactions
- Acquisition of 40 restricted stock units by Director Nancy M. Schlichting from Encompass Health Corp as part of a dividend payment, a transaction between a director and the company.
Stakeholder Impact
- Shareholders: Benefit from the dividend payment and potential alignment of director interests with shareholders through increased equity ownership.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 01/15/2026 | Date of transaction, including dividend payment and RSU award. |
| 01/16/2026 | Date Form 4 was signed and filed. |
Recommendation
holdThis Form 4 reports a routine acquisition of restricted stock units by a director as part of a dividend payment and a pre-arranged 10b5-1 plan. Such a transaction is a standard compensation event and does not provide new fundamental information to alter an investment thesis, thus a 'hold' recommendation is maintained.
Keywords
EHC, Encompass Health, Nancy M. Schlichting, Form 4, Director, Restricted Stock Units, RSU, Dividend, Insider Transaction, Beneficial Ownership, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.